Draft/Working Executive Summery Document
For Global Distribution of Kan Klean Children’s Antimicrobial Diabetic Socks
Description of company and infection protection product: Kan Klean. is a Aboriginal owned Canadian-based company, and is situated on First Nations’ lands. Its Board of Directors is currently comprised of the following individuals: Robert Watts, Simon Johnston, Michael Thrasher and William Mann.
Kan Klean has an ongoing exclusive joint venture/sub-license agreement with Antimicrobial Technologies Group, an American company based in Seattle, which holds the exclusive patented rights to the technologies behind leading infection protection resulting in high performance, antimicrobial textiles.
We believe that Kan Klean, which concerns itself with human wellness, needs to be socially conscious, responsible and involved, especially in the areas representative of our product lines, services, uses, client safety and satisfactions.
With this in mind we have adopted “Client Centered” products identification, development, and marketing and profit strategies. We see our Client and Corporate realities as synonymous in as much as we both seek “Healthy life, Good life, Long life and Peace of Mind”.
We will balance the near global desperate NEED for this product in virtually every human endeavor and the corporate raison d’être, for profit, to the best of our abilities as a globally socially conscious entity. We believe that growth in the spirit of caring will be reflected in our growth in the current marketplace
Harmony must be found between the reality of global human requirements and the control, production, sales, and distribution of products that ensure human safety, health, wellness and social comfort.
At Kan Klean, we believe that “Prosperity” exists where a multi-dimensional alignment of good product, good pricing, good labor practices, good environmental practices and good service are embodied by all our business performance.
By computer research, there are approximately 26,000,000 diabetics in N.A. (CAN/USA) –> 3,250,000 are type 1 and approximately one half of these or 1,625,000 are children, (JDRF client group).
The current Global estimate of diabetes is established 200+ million, with approximately 15% being Type 1; or 30+ million Type one and 170+ million being Type 2
It is estimated that every month 5000+ N. American people suffering from diabetes have an amputation. That makes it 100+ N. American amputations every week!
*Peripheral vascular disease and diabetic foot ulceration. Diabetics are 15 to 40 times more likely to require a lower-limb amputation compared to the general population
There is a diabetic foot amputation globally every 30 seconds
Foot problems are inevitable in diabetes, but proper care with Kan Klean BRAND NAME Socks can assist EVERY DIABETIC from being one amongst those 100 people who eventually have to get amputated weekly in N. America.
Kan Klean Name Brand Antimicrobial Diabetic Sock product stream is developing into providing a first line of defence in The War against Diabetic Amputations. Developed under the title of self-decontaminating textiles, the goal is to provide a simple and quick means to reduce the virulence in the global epidemic of diabetic amputation situations.
Kan Klean is producing (OEM)/ marketing an antimicrobial diabetic sock to fight the epidemic problem of diabetic foot amputations globally. (Made with Antimicrobial Technologies Group technology) One thousand pair of diabetic sock were produced by ATG for sale to the Ontario Indian Federation of Friendship Centers for distribution to Aboriginal diabetics in the Province of Ontario.
ATG technology allows us to guarantee that we can destroy (99.9%) of odor causing bacteria, viruses and molds upon contact. The action/agent is the technology that allows us to bind molecular sized chlorine into the textile where it will not release until it comes into contact with a bacteria, virus or mold. Kan Klean, Brand Name diabetic / sports can be “re-charged” simply by washing the socks in a 5% solution of bleach, such as Ultra Clorox® Regular Bleach to bring them up to full strength. This process is repeatable for the life of the socks!
ATG Treated Textiles prolong the power of chlorine in between launderings to kill 99.9% of the following pathogenic, odor-causing and destructive microbes:
bacteria: Staphylococcus aureus (Staph, including the antibiotic-resistant strain MRSA), Streptococcus pyogenes (Strep), Salmonella choleraesuis, Pseudomonas aeruginosa, Escherichia coli 0157:H7 (E. coli), Mycobacterium
bovis (Tuberculosis), Shigella dysenteriae; these fungi and yeast: Trichophyton mentagrophytes (Athlete's Foot fungus), Aspergillus niger (mildew); and these viruses: Influenza A2 (Flu virus), Adenovirus Type 2, Rhinovirus (Cold virus), Rotavirus, Hepatitis A, Cytomegalovirus, Respiratory Syncytial Virus, Varicella zoster virus (chickenpox, shingles), Herpes Virus 2 (Herpes), Canine parvovirus, Feline parvovirus, Rubella (German measles), HIV (Human Immunodeficiency
Virus), Rubella virus, Adenovirus Type 2, Cytomegalovirus, Human Coronavirus (SARS, colds).
Relative Antimicrobial Power*
* Antimicrobial power is determined by setting a score of 100 as a 99.9% reduction in one hour. Bacteria counts are determined under AATCC Method 100.
“World’s most-powerful antimicrobial Textiles
Antimicrobial Technologies Group
Patented High Performance Textiles are
Anti-Bacterial, Anti-Viral, Anti-fungal and Anti-Odor
With 1000+ times the power of antimicrobial competitors
Kan Klean is in the early stages of market testing and establishing relationships with interested parties in several different disciplines where this product may be of good service to those who may have the highest need for cleanliness as part of their immediate survival requirements.
Kan Klean’s Global Diabetic Amputation Prevention Approach
Kan Klean wants to get this preventative / curative antimicrobial technological advancement in sock apparel directly into the hands of those who need it the most. With that in mind, Kan Klean has chosen to focus its efforts in conjunction with AGT on production and distribution on top quality Brand Name Adult and Children’s antimicrobial diabetic socks and antimicrobial sports socks.
These socks will need to be produced in varying manners suitable for distribution in various geographic areas. Kan Klean’s 1st quality state of the industry socks that will have three advantages over any current product available on the market.
First, Kan Klean’s Brand Name sock fabrics offer 1000 times the power of silver-impregnation against bacteria. Currently silver-impregnation becomes the second-best approach.
Second, Kan Klean’s Brand Name sock fabrics offer the same power against viruses as they do against bacteria and fungus while other approaches offer no protection at all against viruses.
Third, Kan Klean’s Brand Name sock fabrics offer protection for the useful life of the sock, not for just a few cleanings, and it does so for pennies per wash.
Fourth, The Diabetic and sport sock can be used in three ways in any Disaster area/location:  Antimicrobial foot protection for everyone in diseased living conditions caused by disasters of any kind.  Emergency field dressings to keep wounds and amputations sterile until medical attention is available.  Water can be strained through them to obtain potable water. **“Disaster Socks” could be coupled with packaged Chlorine tablets to assure repeated usability in disaster conditions.**
It is the intent of Kan Klean to acquire philanthropic funding that will provide a two tiered dividend aid package to the JDRF and its global Type 1 diabetic group (one half are classified as children)
(1) Provide a Type 1 diabetes basic care and preventative package to every Type1 Diabetic child globally, which includes two pair of antimicrobial socks, intended to eliminate odor causing bacteria and related diabetic foot problems. This currently represents approximately 24 million pair of Kan Klean’s children’s antimicrobial socks.
(2) **The countries that do not have JDRF networks for distribution of these “Ph Socks” (fully wholesale cost covered “Philanthropic Socks”) will necessarily need to be handled by various NGO’s such as the Red Cross, Doctors Without Boarders, Appropriate National & Local Government Agencies, etc.**
(3) Provide the local chapters of the JDRF with a viable, usable preventative foot health care products, antimicrobial sport and or diabetic socks that they can sanction for their local / corporate fundraisers to raise funding for their continuing JDRF research.
** This assists the JDRF fundraising problem of not being “Diabetic Diet Correct” in selling the normal Chocolates and Cookies used as fundraising tools. They do actively look for appropriate fundraising tools continually. **
(A similar scenario with a JDRF contract sanction has just been negotiated with an associate’s new firm that markets “Lapel Stick” – a biodegradable product to stick down the collars of golf shirts to be used as a JDRF fundraising tool)
The above scenario provides our Kan Klean corporation a synergy in product and marketplace that takes into account several factors in our endeavor.
[--] We get our product into use for its intended purpose; first directly through regional / local volunteer JDRF groups and so ultimately through their established international network globally.
(Our goal is to establish a working relationship – i.e. An agreement to raise funds with antimicrobial sport / diabetic sock sales for the JDRF, through a JDRF contractual sanction)
[--] Our need for FDA approved ‘efface claims’ is reduced to a negligible factor once the JDRF agreement is in place).
[--] Each pair of JDRF socks has an attached tag with use, care, maintenance instructions and a Kan Klean web retail supply source.
[--] We can develop the “start up” model here on Vancouver Island with the existing Kan Klean contacts that have been introduced to the concept and are anxious to “field test” the product with their own families.
Global Diabetes facts:
- There are approximately 200, 000,000 Diabetics in the world and this is expected rise threefold by 2030.
- Approximately 15% of the total Diabetic population is Type 1 (25,000,000) and approximately I/2 of the Type 1 total are children (12,500,000)
- $232 B USD was spent in 2007 for prevention and treatment of diabetes and related complications.
- The vast majority (85%) of all diabetes-related amputations are preceded by foot ulcers.
- In most cases, however, diabetic foot ulcers and amputations can be prevented. Researchers have established that between 49% and 85% of all amputations can be prevented. It is imperative, therefore, that healthcare professionals, policymakers and diabetes representative organizations undertake concerted action to ensure that diabetic foot care is structured as effectively as local resources will allow. This will facilitate improvements in foot care for people with diabetes throughout the world and bring about a reduction in diabetic-foot-related morbidity and mortality.
For most of the world, the solutions to the spiraling diabetes pandemic will involve improving access to proven but low-cost therapies, especially in low-income countries that face major environmental and social issues as well as poverty. Developing countries will need to be supported by international and national partnerships but will ultimately need to take ownership and leadership of the solutions that they will need to implement. Country-specific data on the burden of diabetes are required urgently, together with a clear understanding of the extent of national policies for the prevention and care of diabetes. In developing countries, many vertical streams of excellence in delivering diabetes care exist. Yet all too often they work in isolation. Horizontal integration of their efforts would greatly enhance their effectiveness.
The World Bank recently identified seven diabetes treatments that would actually save money if prescribed, even in the poorest regions of the world, and five more that would be highly cost-effective (in the poorest regions, between USD 60 and 660 per life year saved). It is tragic that these treatments are not used more. This situation presents an opportunity. The International Diabetes Federation believes that the fastest and most efficient way to improve health in poor and middle-income countries is to provide cheap, simple, proven treatments to people threatened with diabetes and cardiovascular disease. Doing so will help strengthen primary care, stabilize families, liberate women to seek greater educational and employment opportunities, and improve standards of living.
The International Diabetes Federation commits itself to developing programs for the prevention and treatment of diabetes with partners such as governments, UN organizations (the World Health Organization, Food and Agricultural Organization and UNICEF etc.), World Bank, non-governmental organizations, civil society, philanthropic and service organizations, as well as industry.
Global prevalence of Diabetes 2007 – color coded for % of Population – Darker areas represent highest percentages of diabetes.
Basic Formula for Philanthropically Donated mid grade* diabetic or sports socks:
* Grade is based on basic sock costs
Basic ATG corp. Sock Cost $2.50
Contractor costs: $0.25
Ship / insurance costs: $0.25
Kan Klean corp. costs and expenses: $1.00
Combined Corporate JDRF contribution: $1.00
Total for Charity cost $5.00
The Individual, Team, Corporate or retail fundraiser can sell the product for $10.00 and donate an additional $______ from their regular profit margin to be added to the Kan Klean / ATG $1.00 contribution to the JDRF.(perhaps a $ match with Kan Klean / ATG?)
Note – The basic sock cost reflects a price/quality balance that can reduced with global sized orders with our Asian suppliers. Currently the retail price of “diabetic socks” in N. America runs between $8.00 <- -> $20.00 with none being able to claim the antimicrobial powers of Kan Klean’s ATG treated diabetic socks.
ADDENDUM : RCG
January 4th, 2010 FILE : MT:2010: 001:A
Research : CDA : Foot Care : R&D
5. FootCAREproducts : (1 - $) (2); X-Static : (3 - a) ; (4)
6. BioMechanics : DFC.com ($) : Sears $ : ADW American Diabetes $ : NuLifeMedical $
7. MAYO MEDICAL CLINIC : Nepropathy : Clinic : PubMED – R&D - a : Comments
8. Chlorine-infused Antimicrobial Diabetic Sock : R&D : (Textileworld) (5) (BLOGS)
9. American Podiatric Medical Assoc : (APMA) : General : Specific : antimicrobial footwear : (6)
10. ADA : R&D News (7) : foot infections : Global :
11. ATG - PG : YouTube : KAN KLEAN :
The three obvious critical factors in marketing a product are to know: see PDF
A) One’s own product thoroughly in comparison to other competitive products
B) One’s market region potential : (1) volume potential (2) affordability; and, (3) reasonable availability of products; and,
C) The Supplier’s capabilities
In Preparing a Marketing Strategy the Critical Agreement Factors Are:
A) Terms and Conditions Of The Agreement between Principal & Agent
a) Compensation Agreement; which includes Zone Definitions
b) Definition of Applicable Jurisdiction Of Law In The Event Of Contract Disputes; and
c) Exit Clauses – in the event of either Party desiring to Cease the Agreement
B) Liability Underwriting Provisions
Section A : The Agreement : To be provided by the Principal
Section B : The Marketing Strategies : To be Provided By the Agent : Vancouver Island
a) Native-based : Contact all Tribal Councils & Health Care Providers
b) Non-Native based : Survey existing marketing by competitive products; and, introduce line to market suppliers and directly to know direct client bases
c) Create Pricing Schedules as based upon competitive products
d) Determine Base Line Product Availability In Order To Commence Marketing : Prices & Availability
Section C : The Competition : R&D to be conducted in defined zone by Agent
Submitted By :
Ralph Charles Goodwin : Goodwin.firstname.lastname@example.org : GWE : © 2 : CV